SNYR logo

SNYR
Synergy CHC Corp

577
Mkt Cap
$6.5M
Volume
505,944.00
52W High
$4.00
52W Low
$0.55
PE Ratio
-0.60
SNYR Fundamentals
Price
$0.62
Prev Close
$0.5753
Open
$0.8004
50D MA
$1.29
Beta
-0.21
Avg. Volume
20,330.37
EPS (Annual)
-$1.27
P/B
-0.30
Rev/Employee
$1.09M
$42.18
Loading...
Loading...
News
all
press releases
Synergy CHC Shares Surge Nearly 100% In After-Hours Trading: What's Going On?
Synergy CHC stock surges nearly 100% after-hours following S-8 filing registering 2.25 million shares.read more...
Benzinga·1d ago
News Placeholder
More News
News Placeholder
HealthEquity (HQY) Beats Q4 Earnings and Revenue Estimates
HealthEquity (HQY) delivered earnings and revenue surprises of +7.09% and +0.52%, respectively, for the quarter ended January 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·29d ago
News Placeholder
Ascend Wellness Holdings, Inc. (AAWH) Reports Q4 Loss, Beats Revenue Estimates
Ascend Wellness Holdings, Inc. (AAWH) delivered earnings and revenue surprises of -39.13% and +0.46%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Synergy CHC Corp. (SNYR) Meets Q3 Earnings Estimates
Synergy CHC Corp. (SNYR) delivered earnings and revenue surprises of 0.00% and -26.51%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5mo ago
News Placeholder
DocGo Inc. (DCGO) Reports Q3 Loss, Beats Revenue Estimates
Motion Acquisition (DCGO) delivered earnings and revenue surprises of -22.22% and +0.59%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5mo ago
News Placeholder
Solventum (SOLV) Surpasses Q3 Earnings and Revenue Estimates
Solventum (SOLV) delivered earnings and revenue surprises of +4.90% and +0.33%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5mo ago
<
...
1
>

Latest SNYR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.